Letter to the EditorFull Access
Published Online:1 Mar 2005https://doi.org/10.1176/appi.ajp.162.3.625
- Cited by
- 2 March 2018 | ACS Chemical Neuroscience, Vol. 9, No. 4
- 8 August 2011 | Journal of Psychopharmacology, Vol. 26, No. 6
- British Journal of Hospital Medicine, Vol. 72, No. 2
- 21 December 2010 | Therapeutic Advances in Neurological Disorders, Vol. 4, No. 1
- Journal of Clinical Psychopharmacology, Vol. 28, No. 4
- 4 June 2008 | Movement Disorders, Vol. 23, No. 9
- 7 December 2007 | Movement Disorders, Vol. 23, No. 3
- 1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 9, No. 2
- 1 January 2006 | Human Psychopharmacology: Clinical and Experimental, Vol. 21, No. 7
- 29 November 2016 | Annals of Pharmacotherapy, Vol. 40, No. 4
- 12 July 2009 | The World Journal of Biological Psychiatry, Vol. 7, No. 2
- LOUAI BILAL,
M.D., M.S. , - CARLOINE TSAI,
Pharm.D. , - JAMES J. GASPER,
Pharm.D. , and - J. CHARLES NDLELA,
M.D., M.P.H. ,
1 December 2005 | American Journal of Psychiatry, Vol. 162, No. 12- LOUAI BILAL,